Binding sites forl-glutamate in the central nervous system of the rat

The regional distribution of 2-amino-4-phosphonobutyrate (APB)/chloride-insensitivel-[³H]glutamate binding sites in the rat central nervous system was compared with that of APB/chloride-sensitive and with sodium-dependent binding sites. The distribution of APB-sensitive and APB-insensitive sites was not corelated, but the latter was identical to that of the sodium-dependent sites. The pharmacological specificity of the APB-insensitive sites was not consistent with that of an N-methylaspartate-preferring receptor, and was also different from the specificity determined for the sodium-dependent sites. The APB-insensitive sites appear to be unrelated to any other previously described excitatory amino acid binding site.Dedicated to K. A. C. Elliott on his 80th birthday.     

The Biodiversity Crisis: Lessons from Phylogenetic Sagas

The future of the world’s biodiversity involves preservation of individual species and, more importantly, preservation of the natural process by which the biosphere is populated. Inherited history allows species to carry within them the ability to adapt to changing circumstances. But inherited history also sets the limits for adaptation. Evolutionary potential is thus locked within shared history. Extinction removes, speciation replenishes. We must implement conservation policies that mimic the biotic expansion that sets the stage for speciation. If we do not provide space for species to spread out and find their own futures, building biodiversity reserves is tantamount to attempting to maintain standing diversity by blocking evolution. We must preserve as many species, associations, and places as possible in a geographic context large enough so that individual species may expand and contract and evolutionary dynamics can have free rein to shape the future.     

Biosynthesis of isoprenoids, polyunsaturated fatty acids and flavonoids in Saccharomyces cerevisiae

Industrial biotechnology employs the controlled use of microorganisms for the production of synthetic chemicals or simple biomass that can further be used in a diverse array of applications that span the pharmaceutical, chemical and nutraceutical industries. Recent advances in metagenomics and in the incorporation of entire biosynthetic pathways into Saccharomyces cerevisiae have greatly expanded both the fitness and the repertoire of biochemicals that can be synthesized from this popular microorganism. Further, the availability of the S. cerevisiae entire genome sequence allows the application of systems biology approaches for improving its enormous biosynthetic potential. In this review, we will describe some of the efforts on using S. cerevisiae as a cell factory for the biosynthesis of high-value natural products that belong to the families of isoprenoids, flavonoids and long chain polyunsaturated fatty acids. As natural products are increasingly becoming the center of attention of the pharmaceutical and nutraceutical industries, the use of S. cerevisiae for their production is only expected to expand in the future, further allowing the biosynthesis of novel molecular structures with unique properties.     

The tail of a chaperonin: the C-terminal region of Esctierichia coli GroEL protein

The active form of the KSP60 molecular chaperone of Escherichia coli, GroEL, is a pair of seven-membered rings. We have used site-directed mutagenesis to construct forms of the 547-amino-acid monomer truncated at the C-terminus. We show here that forms that are 520 amino acids long or longer are close to being fully functional. Removing one further amino acid, however, results in a protein, GroEL519, which retains little function. This truncated form is metabolically stable but is not recovered from the cell in particle form. When synthesized at high levels, it prevents the normal assembly of GroEL547 present in the same cell. When synthesized at low levels, it can be included, probably at low molar ratios, in particles formed by assembly-competent forms of GroEL. This can be seen as partial complementation of the temperature-sensitive mutant groEL44. We conclude that amino acid 520 is cruical for particle assembly. GroEL516 has in vivo properties similar to those of GroEL519, but the still shorter form, GroEL504, appears to be inactive.